SIRT7 promotes lung cancer progression by destabilizing the tumor suppressor ARF

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• Sirtuin 7 (SIRT7) is an NAD+-dependent deacetylase implicated as an oncogene in various cancers.
• The precise mechanisms by which SIRT7 promotes lung cancer progression are not fully understood.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying SIRT7's oncogenic role in lung cancer.
• To investigate the interaction between SIRT7 and the tumor suppressor alternative reading frame (ARF) in non-small-cell lung cancer (NSCLC).

Main Methods:

• Investigated SIRT7-ARF interactions using co-immunoprecipitation and Western blotting.
• Assessed ARF degradation pathways via proteasome inhibition assays.
• Evaluated the impact of SIRT7 on NSCLC cell proliferation in vitro and in a mouse xenograft model.
• Analyzed human lung adenocarcinoma transcriptome data for correlations between SIRT7 expression and ARF-regulated genes.

Main Results:

• SIRT7 directly interacts with and destabilizes the tumor suppressor ARF.
• SIRT7 binding prevents ARF-nucleophosmin interaction, promoting ARF's proteasomal degradation.
• SIRT7-mediated ARF degradation enhances protumorigenic gene expression and stimulates NSCLC cell proliferation in vitro and in vivo.
• Human lung adenocarcinoma data show a correlation between high SIRT7 expression and increased activity of genes normally repressed by ARF.

Conclusions:

• SIRT7 promotes NSCLC progression by targeting the tumor suppressor ARF for degradation.
• Disrupting the SIRT7-ARF signaling pathway offers a potential therapeutic strategy for mitigating NSCLC.
• Stabilizing ARF by inhibiting SIRT7 may attenuate cancer cell proliferation.